Navigation Links
Health Robotics to Launch Germany's Installations of i.v.STATION(TM) at Charite-Universitatsmedizin Berlin

BOZEN, Italy, July 20 /PRNewswire/ -- Health Robotics today announced that it has signed a definitive agreement with Charite-Universitatsmedizin Berlin. Charite will install an i.v.STATION robot at its Centrum 14 during the second half of 2009.

The primary challenges in today's IV Admixture operations are serious medication errors, high costs, turn-around time, waste, regulatory issues, lack of audit trails, motion injuries, space constraints and difficulty in maintaining adequate and trained clinical staff. The i.v.STATION robot that automatically compounds non-hazardous IV doses and delivers them to the hospital staff in a ready-to-administer format for antibiotics, pain therapy, anti-virals, epidurals, and other IV and injectable doses. i.v.STATION was designed to address the above-mentioned industry-challenges, and to overcome the fact that until now, the range of products and technology available to mitigate these issues has consisted of variations on the IV "piggyback" bag, outsourcing of IVs, and mid-1990s-developed automated solutions that have seen very limited adoption and success.

"i.v.STATION represents a revolutionary approach in the quest for safe, accurate, efficient, and cost effective I.V. Admixtures. It offers unprecedented error reduction, accuracy and sterility benefits, nursing staff labor savings, all within a scalable and fail-safe architecture. We are delighted to be the first German hospital to test the exciting new technology of i.v.STATION robot," stated PD Dr. Hartmut Radtke, Chief of Production of Blood Products at Charite-Universitatsmedizin Berlin.

"We are ecstatic to have been selected by such a prestigious health care institution as Charite-Universitatsmedizin-Berlin, well known throughout the world for both its research and patient care excellence. It makes everyone at our company, especially those of us coming from Sud-Tirol very proud of what we have accomplished with i.v.STATION this year and to have the great opportunity to launch Health Robotics' direct operations in the Federal Republic of Germany," stated Werner Rainer, CEO of Health Robotics.

About Health Robotics:

Health Robotics is the global leading supplier of life-critical intra-venous medication preparation, compounding, and dispensing Robots, providing health care facilities around the world with robotic technology and software automation solutions. The world-leading solutions CytoCare [hazardous IVs] and i.v.STATION [non-hazardous IVs] have and will greatly contribute to ease global hospitals' & clinics' growing pressures to improve patient safety through effective and efficient production of sterile, safe, accurate, and ready-to-administer IVs, to decrease life-threatening medication errors and cross-contamination risks, and to work more efficiently, increase throughput, reduce waste, and contain spiraling costs.

About Charite-Universitatsmedizin Berlin:

The Charite is one of the oldest hospitals in Germany and among the largest of university clinics in Europe today. With a history spanning almost three centuries, the Charite has produced eight Nobel prize winners and has a worldwide reputation for excellence in medicine and research. Currently, with a staff of 10,400 employees, the hospital annually handles in excess of 3,000 inpatient beds, 130,000 inpatient cases and 497,000 outpatient cases under the motto: "Research, Teaching, Healing, Helping". Almost 2,600 scientists and doctors at the Charite-Universitatsmedizin Berlin are working on developing new therapies and optimizing existing treatments. In order to best organize teaching, research, and patient care, the Charite-Universitatsmedizin established 17 ChariteCenters, housing a total of 107 clinics and institutes of medicine.

    For additional information, please contact:
    Health Robotics
    Gaspar G. DeViedma
    Europe: +39-346-963-4934
    USA: +1-609-980-7976

SOURCE Health Robotics
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Anthony Hess to Lead SAIC Health Solutions Business Unit
2. avVaa World Health Care Products Inc. Announces Web Site Design for Neuroskin(R) Psoriasis Relief DRTV Campaign
3. American Medical Informatics Association (AMIA) Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certification
4. Health Robotics Expands and Diversifies Global Channel Strategies With Joint-Ventures & Direct Operations
5. avVaa World Health Care Products, Inc. Signs Agreement with 3PL Worldwide, Inc., for Order Management & Fulfillment for avVaas Product
6. avVaa World Health Care Products, Inc. Announces Engagement of Koeppel Direct for their DRTV-Direct Response Television Media Buying Campaign
7. Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer
8. BIO Ventures for Global Health Announces Management Changes
9. Expanding Indianas Breakthroughs in Health Information Technology (Exibhit Indiana): Initiative to Advance the States Health IT National Leadership and Assets Launched to Bring More Awareness to Sector
10. The MedZilla Report: May 2009 Employment Outlook for Biotech/Pharma/Health
11. Healthy Advice Networks Announces Improved Patient Outcomes in Physicians Offices with Healthy Advice Programs
Post Your Comments:
(Date:6/27/2016)... June 27, 2016  Sequenom, Inc. (NASDAQ: ... healthier lives through the development of innovative products and ... the United States denied its petition ... claims of Sequenom,s U.S. Patent No. 6,258,540 (",540 Patent") ... established by the Supreme Court,s Mayo Collaborative Services v. ...
(Date:6/27/2016)... Chapel Hill, N.C. (PRWEB) , ... June 27, ... ... of U.S. commercial operations for Amgen, will join the faculty of the ... will serve as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... Wausau, WI (PRWEB) , ... June 23, 2016 ... ... probiotic supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, ... supplements for over 35 years, is proud to add Target to its list ...
Breaking Biology Technology:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
Breaking Biology News(10 mins):